GB1397621A - Derivatives or homologues of cysteine - Google Patents

Derivatives or homologues of cysteine

Info

Publication number
GB1397621A
GB1397621A GB1860672A GB1860672A GB1397621A GB 1397621 A GB1397621 A GB 1397621A GB 1860672 A GB1860672 A GB 1860672A GB 1860672 A GB1860672 A GB 1860672A GB 1397621 A GB1397621 A GB 1397621A
Authority
GB
United Kingdom
Prior art keywords
alanine
acid
ethylthio
propionic acid
benzylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1860672A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of GB1397621A publication Critical patent/GB1397621A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/56—Radicals substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1397621 Thio-aminoacid derivatives; pantothenic acid derivatives L'OREAL 21 April 1972 [23 April 1971] 18606/72 Headings C2C and C2V The invention comprises the compounds 3-(2- ethyl-hexylthio)-alanine, 3-hexadecylthio-alanine, 3-octadecylthio-alanine, 3-(octadec-9- enylthio)-alanine, 1,4-bis-(3-alaninylthio)but-2- ene, 3-(2,3-dihydroxy-propylthio)-alanine, 3- (2,2-dimethoxy-ethylthio)-alanine, 3-(3,3-diethoxy-propylthio)-alanine, 3-(1,2-propylenedioxy-ethylthio)-alanine, 3-(2,2-ethylenedioxypropylthio)-alanine, 3-#-ureido-ethylthio-alanine, 3-#-phenylacetamidoethylthio-alanine, 3-#-nicotinamidoethylthio-alanine, 3-[2-(2,4- dihydroxy - 3,3 - dimethyl - butyramido)- ethylthio]-alanine, 3-[9,11-dihydroxy-10,10- dimethyl - 4,8 - dioxo - 3,7 - diaza - undecylthio]- alanine, (this being a pantothenic acid derivative), 2,3-dihydroxy-1,4-bis-(3-alaninylthio)- butane, 3-(2-thenylthio) alanine, 2-acetamido-3- (2,4-dichloro-benzylthio)-propionic acid, 2- amino-4-(#-amino-ethylthio)-butyric acid, 3-(2- p - toluenesulphonamido - ethylthio) - alanine, 3-furfurylthio-alanine, 3-tetrahydrofurfurylthio-alanine, 3-(2-pyridyl-methylthio)-alanine, 3-(2-pyridyl-thio)-alanine, 3-[2-(2-pyridyl)- ethylthio]-alanine, 3-o-methoxybenzylthio-alanine, 3-p-butoxybenzylthio-alanine, 3-mfluorobenzylthio-alanine, 3-p-fluorobenzylthioalanine, 3-o-fluorobenzylthio-alanine, 3-(4- isopropyl-benzylthio)-aniline, 2-methanesulphonamido-3-dodecylthio-propionic acid, 5- ureido-3-thia-hexanedioic acid, 3-benzylthio-2- (9-octadecene-amido)-propionic acid, 2-propionamido-3-benzylthio-propionhydroxamic acid, 2,2<SP>1</SP>-bis-(3-alaninylthio)-diethylsulphone and its N,N<SP>1</SP>-diacetyl derivative, 3-(#-piperidinocarbonyl-ethylthio)-alanine, 2-acetamido-3- (pyrrolidinocarbonyl.methylthio)-propionic acid, 5-dodecanamido-3-thia-hexanedioic acid, 3-(1- naphthyl-methylthio)-alanine, methyl 2-amino- 4-o-chlorobenzylthio-butyrate hydrochloride, 2-propionamido-4-tetradecylthio-butyric acid, 1,4 - bis - [3 - (1 - amino - 1 - carboxypropyl)- thio]-but-2-ene, methyl 2-amino-3-o-chlorobenzylthio-propionate, N-(1-carboxyl-2-o-chlorobenzylthio-ethyl)-succinamic acid, 2-acetamido. 3-o-chlorobenzylthio-propionic acid, 2-acetamido - 3 - (2,6 - dichloro - benzylthio) - propionic acid, 2-acetamido-3-(3,4-dichloro-benzylthio)-propionic acid, 3-octylthio-2-propionamido-propionic acid, and propyl 2-amino-3- benzylthio-propionate; and also compositions suitable for application to the hair or the skin which comprises at least one compound as above and a suitable vehicle, with the proviso that (i) the composition does not contain a perfume and (ii) the composition is not orally ingestible. General methods for preparing these compounds are given, with at least one method indicated for each compound. Intermediates.-2 - Amino - 3 - (2,4 - dichlorobenzylthio)-propionic acid is prepared from cysteine hydrochloride and 2,4-dichlorobenzyl chloride in the presence of sodium ethoxide. The 3-(o-chlorobenzylthio) compound is obtained similarly. Triethylamine pantothenate is prepared from calcium pantothenate, oxalic acid and triethylamine. Reference has been directed by the Comptroller to Specification 1,191,042.
GB1860672A 1971-04-23 1972-04-21 Derivatives or homologues of cysteine Expired GB1397621A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU63056 1971-04-23

Publications (1)

Publication Number Publication Date
GB1397621A true GB1397621A (en) 1975-06-11

Family

ID=19726687

Family Applications (3)

Application Number Title Priority Date Filing Date
GB3461074A Expired GB1397623A (en) 1971-04-23 1972-04-21 Composition for topical application for counteracting the greasy appearance of the head of hair and/or the skin
GB1860672A Expired GB1397621A (en) 1971-04-23 1972-04-21 Derivatives or homologues of cysteine
GB3461174A Expired GB1397624A (en) 1971-04-23 1972-04-21 Composition ror oral administration for counteracting the greasy appearance of the head of hair and or the skin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB3461074A Expired GB1397623A (en) 1971-04-23 1972-04-21 Composition for topical application for counteracting the greasy appearance of the head of hair and/or the skin

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB3461174A Expired GB1397624A (en) 1971-04-23 1972-04-21 Composition ror oral administration for counteracting the greasy appearance of the head of hair and or the skin

Country Status (11)

Country Link
JP (1) JPS6015602B1 (en)
AT (1) AT341676B (en)
BE (1) BE782480A (en)
CA (1) CA1024444A (en)
CH (1) CH556667A (en)
DE (1) DE2219726C2 (en)
FR (1) FR2133991B1 (en)
GB (3) GB1397623A (en)
IT (1) IT974905B (en)
LU (1) LU63056A1 (en)
NL (1) NL7205443A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002070A1 (en) * 2000-06-30 2002-01-10 Unilever Plc Cosmetic compositions containing substituted sulfonamide derivatives
CN105616179A (en) * 2016-02-24 2016-06-01 上海尚雪实业有限公司 Active factor COAWA for activating affinity interaction and preparation and application thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2447189A1 (en) * 1979-01-29 1980-08-22 Oreal NOVEL COSMETIC COMPOSITIONS FOR THE TREATMENT OF HAIR AND SKIN CONTAINING AS ACTIVE INGREDIENTS OF ALKYLENE-DITHIOETHERS
EP0236533A1 (en) * 1984-09-14 1987-09-16 Sumitomo Pharmaceuticals Company, Limited Permanent wave preparation
CA2799157A1 (en) * 2009-05-06 2010-11-11 Xianqi Kong Ammo acid derivatives for the treatment of neuropathic pain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR67188E (en) * 1951-07-06 1957-11-25 Materiel Telephonique Code translators device

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002070A1 (en) * 2000-06-30 2002-01-10 Unilever Plc Cosmetic compositions containing substituted sulfonamide derivatives
US6432427B1 (en) 2000-06-30 2002-08-13 Unilever Hope & Personal Care Usa, Division Of Conopco, Inc. Cosmetic compositions containing substituted sulfonamide derivatives
CN105616179A (en) * 2016-02-24 2016-06-01 上海尚雪实业有限公司 Active factor COAWA for activating affinity interaction and preparation and application thereof
CN105616179B (en) * 2016-02-24 2018-11-06 上海尚雪实业有限公司 A kind of active factors COAWA of activation affinity interaction and its preparation and application

Also Published As

Publication number Publication date
BE782480A (en) 1972-10-23
GB1397623A (en) 1975-06-11
FR2133991B1 (en) 1976-05-14
JPS6015602B1 (en) 1985-04-20
LU63056A1 (en) 1972-12-11
CH556667A (en) 1974-12-13
ATA350572A (en) 1977-06-15
DE2219726C2 (en) 1984-09-27
FR2133991A1 (en) 1972-12-01
CA1024444A (en) 1978-01-17
IT974905B (en) 1974-07-10
GB1397624A (en) 1975-06-11
DE2219726A1 (en) 1972-11-09
AU4144972A (en) 1973-10-25
AT341676B (en) 1978-02-27
NL7205443A (en) 1972-10-25

Similar Documents

Publication Publication Date Title
KR920021578A (en) Phosphno / biaryl substituted dipeptide derivatives
ES2186721T3 (en) SUBSTITUTED AZAINDOLYLIDENE COMPOUNDS AND PROCESS FOR PREPARATION.
ATE12492T1 (en) ARYLOXYPROPANOLAMINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS.
BR9509212A (en) Compound pharmaceutical composition method of inhibiting prostaglandin H synthase in a mammal method of treating an inflammatory disease in a mammal and method of treating pyresis in a mammal
RU93050199A (en) DEOXITAXOLS, METHODS OF THEIR PRODUCTION, INTERMEDIATE COMPOUNDS, PHARMACEUTICALS
DK443482A (en) PROCEDURE FOR THE PREPARATION OF CARBOXYLIC ACID DERIVATIVES
AR003947A1 (en) USE OF AN EFFECTIVE AMOUNT OF AT LEAST ONE RETINOID TYPE COMPOUND AS AN ACTIVE AGENT IN A COSMETIC COMPOSITION OR FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION, AND SPECIFIC COMPOUNDS OF SUCH TYPE.
JPS57212157A (en) Collagenase inhibitory compound
GB1397621A (en) Derivatives or homologues of cysteine
KR900004658A (en) Disubstituted benzylamine, preparation method thereof, use thereof as medicament and synthesis agent thereof
PT977749E (en) BIAROMATIC COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS UNDERSTANDING THE SAME
ES419029A1 (en) Benzylidene camphor derivatives and their use for protection against actinic rays
ATE205699T1 (en) DEHAIR REMOVAL COMPOSITIONS CONTAINING SULFHYDRYL COMPOUNDS
ES522436A0 (en) ANALOGUE PROCEDURE FOR PREPARING ACID (R, S) -5-AMINO-HEPTA-5,6-DIENOIC, ACID (S) -4-AMINO-HEPTA-5,6-DIENOIC OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS.
GB1268956A (en) Derivatives of 2-(halophenoxy or halophenylthio) alkanamides and their preparation
BR7408315D0 (en) PROCESS IMPROVEMENT FOR THE SYNTHESIS OF A C1-C7 ALIFACTIC HYDROCARBILE ESTER OF AN N- (2,6-DI (C1-C7 ALKYL) FENIL) ALPHA-AMINOCARBOXYLIC ACID
FR2393791A1 (en) N, N&#39;-DISUBSTITUTED P-PHENYLENEDIAMINES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS ANTI-OXIDANTS AND ANTI-OZONANTS
SE7901706L (en) BENZYLIDE DERIVATIVES
ES390778A1 (en) Halogen-substituted phenyl-alkylamines and their derivatives
GB1554841A (en) 2,4 - dichlorophenyl - imidazolyl - ethan - ones and -ols a process for their preparation and their use as medicaments
JPH10512870A (en) Thiol derivatives having metallopeptidase inhibitory activity
SU467898A1 (en) The method of obtaining -rodanethylamide aryloxyalkylcarboxylic acid
ES546860A0 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 1- (AMINO-PHENYL) -2-AMINO-ETHANONE
ES426123A2 (en) 2-propyl-5-thiazole carboxylates
BR112022012258A2 (en) CRYSTALLINE HROMYDRIDE SALT OF AN EZH2 INHIBITOR, ITS PREPARATION AND USEFUL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee